Company / Income Tax
Adaptimmune Therapeutics PLC Income Tax History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.6M
FY2024
5-year range
$162.0K / $3.6M
FY2020-FY2024
Trend
+167.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 9 years, ranging from $162,000 in FY2020 to $4M in FY2024.
Based on SEC 10-K filings.
$4M in FY2024 with a 5-year CAGR of +71.4%.
Increased from $2M to $4M over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +65.4%
- 5-Year CAGR
- +71.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +71.4%, indicating consistent growth.
- In FY2024, income tax increased 167.7% year-over-year.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.6M | +167.7% |
| FY2023 | $1.3M | -46.5% |
| FY2022 | $2.5M | +215.7% |
| FY2021 | $791.0K | +388.3% |
| FY2020 | $162.0K | -33.1% |
| FY2019 | $242.0K | -51.3% |
| FY2018 | $497.0K | +10.2% |
| FY2017 | $451.0K | -49.4% |
| FY2016 | $892.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026